{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["104(2)"],"submitter":["Hoareau-Aveilla C"],"pubmed_abstract":["Anaplastic large-cell lymphoma, a T-cell neoplasm, is primarily a pediatric disease. Seventy-five percent of pediatric anaplastic large-cell lymphoma cases harbor the chromosomal translocation t(2;5)(p23;q35) leading to the ectopic expression of NPM-ALK, a chimeric tyrosine kinase. NPM-ALK consists of an N-terminal nucleophosmin (NPM) domain fused to an anaplastic lymphoma kinase (ALK) cytoplasmic domain. Pediatric NPM-ALK<sup>+</sup> anaplastic large-cell lymphoma is often a disseminated disease and young patients are prone to chemoresistance or relapse shortly after chemotherapeutic treatment. Furthermore, there is no gold standard protocol for the treatment of relapses. To the best of our knowledge, this is the first study on the potential role of the microRNA, miR-497, in NPM-ALK<sup>+"],"journal":["Haematologica"],"pagination":["347-359"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6355472"],"repository":["biostudies-literature"],"pubmed_title":["miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells."],"pmcid":["PMC6355472"],"pubmed_authors":["Congras A","Dozier C","Brousset P","Hoareau-Aveilla C","Labourdette D","Quelen C","Lamant L","Meggetto F","Caillet N"],"additional_accession":[]},"is_claimable":false,"name":"miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.","description":"Anaplastic large-cell lymphoma, a T-cell neoplasm, is primarily a pediatric disease. Seventy-five percent of pediatric anaplastic large-cell lymphoma cases harbor the chromosomal translocation t(2;5)(p23;q35) leading to the ectopic expression of NPM-ALK, a chimeric tyrosine kinase. NPM-ALK consists of an N-terminal nucleophosmin (NPM) domain fused to an anaplastic lymphoma kinase (ALK) cytoplasmic domain. Pediatric NPM-ALK<sup>+</sup> anaplastic large-cell lymphoma is often a disseminated disease and young patients are prone to chemoresistance or relapse shortly after chemotherapeutic treatment. Furthermore, there is no gold standard protocol for the treatment of relapses. To the best of our knowledge, this is the first study on the potential role of the microRNA, miR-497, in NPM-ALK<sup>+","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Feb","modification":"2025-05-18T11:31:15.6Z","creation":"2025-05-18T11:31:15.6Z"},"accession":"S-EPMC6355472","cross_references":{"pubmed":["30262555"],"doi":["10.3324/haematol.2018.195131"]}}